What’s new from the American Society of Hematology 2010 meeting?

Written by Victoria Louise Crump-Haill – Digital Strategist/Account Director‏

Recently an increasing number of therapies across a wide range of haematological cancers have been investigated in the elderly population. These have included rituximab in patients with chronic lymphocytic leukaemia (CLL) and diffuse large B-Cell lymphoma (DLBCL), dasatinib and imatinib in chronic myeloid leukaemia (CML), dasatinib in de novo Philadelphia positive acute lymphocytic leukaemia (Ph+ ALL) and lenolidamide in multiple myeloma (MM). The results of these trials were presented at ASH 2010.

You can read the full review on ecancer.

Brandcast will be running Europe’s largest ever educational meeting focussed on the elderly blood cancer patient in Rome, March 18-20 2011. 1000 delegates and an leading faculty of experts will gather for the inaugural Blood Cancer in The Elderly European Expert Forum: Ageing and co-morbidity in haematological oncology.

Comments are closed.


We'd love to work with you

Contact Us

16-17 Little Portland Street

+44 (0)20 7291 5070


8 Cross Street, Level 28
PWC Building
Singapore, 048424

+44 (0)20 7291 5070

Suffolk Coast

Basepoint Unit 12a
The Havens
Ransomes Euro Park
Ipswich, IP3 9BF

T. +44 (0)1473 722 794

Call Us